text
"['\n4. 재무제표\n가. 재무상태표\n반 기 재 무 상 태 표\n제 71 기 반기 : 2019년 06월 30일 현재\n제 70 기\xa0 \xa0 \xa0 \xa0 : 2018년 12월 31일 현재\n한화생명보험주식회사\n(단위 : 원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 목\n주\xa0 석\n제 71 (당) 반기\n제 70 (전)기\n자\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 산\n\u3000\nI. 현금및현금성자산\n5,6,7\n391,286,748,578\n1,412,191,890,071\nII. 예치금\n5,6,7\n22,724,245,005\n2,038,331,659\nIII. 당기손익인식유가증권\n5,6,8\n2,554,382,578,848\n1,330,761,215,106\nIV. 매도가능유가증권\n5,6,8\n23,796,946,189,260\n23,585,326,040,876\nV. 만기보유유가증권\n5,6,8\n33,994,804,132,429\n33,614,053,186,610\nVI. 관계ㆍ종속기업투자\n9\n6,760,430,168,255\n5,760,026,276,921\nVII. 대출채권\n5,6,10\n20,972,108,839,857\n20,554,538,372,537\nVIII. 유형자산\n12,13\n1,470,954,400,498\n1,456,741,792,281\nIX. 투자부동산\n12,13\n2,067,382,099,326\n2,094,515,099,428\nX. 무형자산\n13\n89,590,215,947\n82,703,510,317\nXI. 파생상품자산\n5,6,11\n79,866,302,052\n331,535,742,386\nXII. 순확정급여자산\n20\n-\n13,198,515,909\nXIII. 사용권자산\n13\n32,393,617,437\n-\nXIV. 당기법인세자산\n49,569,957,730\n-\nXV. 기타금융자산\n5,6,14\n1,014,775,755,898\n874,772,287,723\nXVI. 기타자산\n15\n1,706,487,054,482\n1,735,067,069,086\nXVII. 특별계정자산\n19\n22,028,793,865,293\n21,454,998,652,878\n자\xa0 \xa0 \xa0 산\xa0 \xa0 \xa0 총\xa0 \xa0 \xa0 계\n117,032,496,170,895\n114,302,467,983,788\n부\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 채\n\u3000\nI. 보험계약부채\n16,17\n81,785,967,813,243\n80,240,632,767,941\nII. 계약자지분조정\n18\n816,605,321,943\n571,159,988,569\nIII. 당기법인세부채\n-\n287,072,747,732\nIV. 이연법인세부채\n261,809,611,505\n37,180,370,032\nV. 파생상품부채\n5,6,11\n785,288,566,849\n280,650,276,360\nVI. 순확정급여부채\n20\n6,103,650,497\n-\nVII. 충당부채\n21\n11,003,926,143\n11,207,393,210\nVIII. 기타금융부채\n5,6,22\n728,784,175,987\n537,268,455,630\nIX. 기타부채\n23\n137,255,945,432\n96,081,941,170\nX. 특별계정부채\n19\n21,993,957,612,444\n22,378,744,261,574\n부\xa0 \xa0 \xa0 채\xa0 \xa0 \xa0 총\xa0 \xa0 \xa0 계\n\u3000\n106,526,776,624,043\n104,439,998,202,218\n자\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 본\n\u3000\nI. 자본금\n24\n4,342,650,000,000\n4,342,650,000,000\nII. 기타불입자본\n24\n(438,803,750,750)\n(438,803,750,750)\nIII. 신종자본증권\n25\n1,558,000,197,526\n1,558,000,197,526\nIV. 기타자본구성요소\n26\n1,705,744,754,695\n1,042,450,767,867\nV. 이익잉여금\n27\n3,338,128,345,381\n3,358,172,566,927\n자\xa0 \xa0 \xa0\xa0 본\xa0 \xa0 \xa0\xa0 총\xa0 \xa0 \xa0\xa0 계\n\u3000\n10,505,719,546,852\n9,862,469,781,570\n부\xa0 채\xa0 및\xa0 자\xa0 본\xa0 총\xa0 계\n\u3000\n117,032,496,170,895\n114,302,467,983,788\n나. 포괄손익계산서\n반 기 포 괄 손 익 계 산 서\n제71기 반기 : 2019년 1월 1일부터 2019년 06월 30일까지\n제70기 반기 : 2018년 1월 1일부터 2018년 06월 30일까지\n한화생명보험주식회사\n(단위 : 원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 목\n주석\n제 71 (당) 반기\n제 70 (전) 반기\n3개월\n누적\n3개월\n누적\nI. 영업수익\n4,234,899,992,838\n8,213,886,860,104\n4,516,665,689,648\n8,103,583,238,038\n\xa0 1. 보험료수익\n29\n2,358,565,457,806\n4,724,541,666,766\n2,289,081,641,453\n4,621,588,009,606\n\xa0 2. 재보험수익\n30\n40,490,484,612\n81,188,005,198\n41,107,145,130\n79,547,922,645\n\xa0 3. 이자수익\n28,38\n626,679,201,666\n1,260,840,713,640\n660,009,520,587\n1,327,555,541,146\n\xa0 4. 당기손익인식유가증권 평가 및 처분이익\n28\n11,994,386,434\n23,647,523,822\n2,827,173,686\n5,056,556,093\n\xa0 5. 매도가능유가증권 평가 및 처분이익\n28\n113,830,809,961\n171,155,528,795\n61,786,015,968\n141,660,955,688\n\xa0 6. 외환거래 및 환산이익\n28\n538,624,044,585\n938,710,891,766\n989,732,109,437\n949,147,609,140\n\xa0 7. 파생상품 평가 및 거래이익\n11,28\n142,388,090,162\n187,653,069,060\n13,787,236,686\n68,634,627,125\n\xa0 8. 기타수익\n31,38\n91,343,935,210\n227,588,496,799\n95,318,667,648\n200,129,712,020\n\xa0 9. 특별계정수입수수료\n240,947,550,968\n475,184,020,019\n299,376,042,036\n601,987,022,237\n\xa0 10. 특별계정수익\n19\n70,036,031,434\n123,376,944,239\n63,640,137,017\n108,275,282,338\nII. 영업비용\n4,257,264,075,071\n8,257,884,235,002\n4,368,073,991,852\n7,842,080,332,556\n\xa0 1. 보험계약부채전입액\n16\n859,134,365,386\n1,543,872,124,834\n868,502,733,440\n1,531,063,688,926\n\xa0 2. 지급보험금\n32,38\n1,911,207,244,919\n3,941,004,965,027\n1,856,133,550,096\n3,954,290,192,096\n\xa0 3. 재보험비용\n30\n41,786,084,715\n85,038,033,548\n42,603,195,275\n84,989,873,698\n\xa0 4. 사업비\n33,38\n306,431,728,896\n616,576,562,301\n278,205,372,694\n554,511,957,498\n\xa0 5. 신계약비상각비\n15\n202,841,576,971\n446,799,677,935\n233,076,062,555\n478,397,551,552\n\xa0 6. 재산관리비\n34,38\n61,188,835,244\n104,932,826,130\n58,117,601,991\n95,187,689,474\n\xa0 7. 당기손익인식유가증권 평가 및 처분손실\n28\n1,224,145,081\n1,324,329,493\n193,630,773\n97,701,623\n\xa0 8. 매도가능유가증권 평가 및 처분손실\n28\n126,942,479,009\n242,869,156,230\n4,250,159,647\n19,668,490,616\n\xa0 9. 대출채권및수취채권 평가 및 처분손실\n28\n10,446,527,796\n45,859,716,364\n2,367,775,129\n9,307,599,422\n\xa0 10. 외환거래 및 환산손실\n28\n17,064,264,696\n35,786,748,032\n14,732,742,430\n53,043,527,943\n\xa0 11. 파생상품 평가 및 거래손실\n11,28\n629,639,105,382\n1,031,870,086,112\n927,055,468,737\n913,052,709,780\n\xa0 12. 기타비용\n35\n14,211,468,219\n27,874,749,694\n13,816,649,676\n28,143,197,973\n\xa0 13. 특별계정지급수수료\n5,110,217,323\n10,698,315,063\n5,378,912,392\n12,050,869,617\n\xa0 14. 특별계정비용\n19\n70,036,031,434\n123,376,944,239\n63,640,137,017\n108,275,282,338\nIII. 영업이익(손실)\n(22,364,082,233)\n(43,997,374,898)\n148,591,697,796\n261,502,905,482\nIV. 영업외수익\n36\n79,214,085,591\n169,578,397,971\n33,172,073,421\n100,423,879,309\nV. 영업외비용\n36\n6,775,948,959\n12,423,092,142\n4,586,435,613\n13,457,630,513\nVI. 법인세비용차감전순이익\n50,074,054,399\n113,157,930,931\n177,177,335,604\n348,469,154,278\nVII. 법인세비용\n37\n3,253,892,961\n19,750,384,525\n46,942,092,709\n103,648,687,446\nVIII. 반기순이익\n46,820,161,438\n93,407,546,406\n130,235,242,895\n244,820,466,832\nIX. 법인세비용차감후 기타포괄손익\n297,826,905,107\n663,293,986,828\n(56,983,238,968)\n(205,608,772,175)\n\xa0 1. 당기손익으로 재분류되지 않는 포괄손익\n287,933,457\n2,757,892,564\n913,366,780\n4,167,610,156\n\xa0\xa0 1) 유형자산재평가이익\n287,933,457\n2,757,892,564\n913,366,780\n4,167,610,156\n\xa0 2. 후속적으로 당기손익으로 재분류될 수 있는 포괄손익\n297,538,971,650\n660,536,094,264\n(57,896,605,748)\n(209,776,382,331)\n\xa0\xa0 1) 매도가능금융자산평가손익\n313,081,199,687\n746,627,359,990\n(58,300,836,524)\n(261,025,756,783)\n\xa0\xa0 2) 만기보유금융자산평가손익\n(19,454,427,981)\n(39,494,056,945)\n(11,602,933,339)\n(24,472,908,923)\n\xa0\xa0 3) 관계ㆍ종속기업기타포괄손익지분\n18,510,396,062\n(2,148,485,840)\n11,144,439,371\n22,183,907,271\n\xa0\xa0 4) 위험회피목적파생상품평가손익\n(44,836,473,485)\n(117,180,548,088)\n2,625,249,612\n62,296,870,803\n\xa0\xa0 5) 특별계정기타포괄손익\n30,238,277,367\n72,731,825,147\n(1,762,524,868)\n(8,758,494,699)\nX. 반기총포괄손익\n344,647,066,545\n756,701,533,234\n73,252,003,927\n39,211,694,657\nXI. 주당이익\n\xa0 1. 기본 및 희석주당이익\n36\n73\n152\n297\n다. 자본변동표\n반 기 자 본 변 동 표\n제71기 반기\xa0 : 2019년 1월 1일부터 2019년 6월 30일까지\n제70기 반기\xa0 : 2018년 1월 1일부터 2018년 6월 30일까지\n한화생명보험주식회사\n(단위 : 원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 목\n자\xa0 본\xa0 금\n기타불입자본\n신종자본증권\n기타자본구성요소\n이익잉여금\n총계\n2018.1.1 (전기초)\n4,342,650,000,000\n(438,803,750,750)\n497,930,280,000\n1,414,993,109,658\n3,152,317,784,861\n8,969,087,423,769\nI. 반기총포괄손익\n\xa0 1. 반기순이익\n-\n-\n-\n-\n244,820,466,832\n244,820,466,832\n\xa0 2. 유형자산재평가이익\n-\n-\n-\n4,167,610,156\n-\n4,167,610,156\n\xa0 3. 매도가능금융자산평가손익\n-\n-\n-\n(261,025,756,783)\n-\n(261,025,756,783)\n\xa0 4. 만기보유금융자산평가손익\n-\n-\n-\n(24,472,908,923)\n-\n(24,472,908,923)\n\xa0 5. 관계ㆍ종속기업기타포괄손익지분\n-\n-\n-\n22,183,907,271\n-\n22,183,907,271\n\xa0 6. 위험회피목적파생상품평가손익\n-\n-\n-\n62,296,870,803\n-\n62,296,870,803\n\xa0 7. 특별계정기타포괄손익\n-\n-\n-\n(8,758,494,699)\n-\n(8,758,494,699)\nII. 자본에 직접 인식된 주주와의 거래\n\xa0 1. 연차배당\n-\n-\n-\n-\n(105,194,635,000)\n(105,194,635,000)\n\xa0 2. 신종자본증권 발행\n-\n-\n1,060,069,917,526\n-\n-\n1,060,069,917,526\n\xa0 3. 신종자본증권 배당\n-\n-\n-\n-\n(21,385,787,205)\n(21,385,787,205)\n2018.6.30 (전반기말)\n4,342,650,000,000\n(438,803,750,750)\n1,558,000,197,526\n1,209,384,337,483\n3,270,557,829,488\n9,941,788,613,747\n2019.1.1 (당기초)\n4,342,650,000,000\xa0\n(438,803,750,750)\n1,558,000,197,526\xa0\n1,042,450,767,867\xa0\n3,358,172,566,927\xa0\n9,862,469,781,570\xa0\nI. 반기총포괄손익\n\xa0 1. 반기순이익\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n93,407,546,406\xa0\n93,407,546,406\xa0\n\xa0 2. 유형자산재평가이익\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n2,757,892,564\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n2,757,892,564\xa0\n\xa0 3. 매도가능금융자산평가손익\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n746,627,359,990\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n746,627,359,990\xa0\n\xa0 4. 만기보유금융자산평가손익\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n(39,494,056,945)\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n(39,494,056,945)\n\xa0 5. 관계ㆍ종속기업기타포괄손익지분\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n(2,148,485,840)\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n(2,148,485,840)\n\xa0 6. 위험회피목적파생상품평가손익\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n(117,180,548,088)\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n(117,180,548,088)\n\xa0 7. 특별계정기타포괄손익\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n72,731,825,147\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n72,731,825,147\xa0\nII. 자본에 직접 인식된 주주와의 거래\n\xa0 1. 연차배당\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n(75,139,025,000)\n(75,139,025,000)\n\xa0 2. 신종자본증권 배당\n-\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0\xa0 -\xa0\n(38,312,742,952)\n(38,312,742,952)\n2019.6.30 (당반기말)\n4,342,650,000,000\xa0\n(438,803,750,750)\n1,558,000,197,526\xa0\n1,705,744,754,695\xa0\n3,338,128,345,381\xa0\n10,505,719,546,852\xa0\n라. 현금흐름표\n반 기 현 금 흐 름 표\n제71기 반기 : 2019년 1월 1일부터 2019년 06월 30일까지\n제70기 반기 : 2018년 1월 1일부터 2018년 06월 30일까지\n한화생명보험주식회사\n(단위 : 원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 목\n주 석\n제 71 (당) 반기\n제 70 (전) 반기\nI. 영업활동으로 인한 현금흐름\n(1,293,451,980,475)\n1,609,282,748,391\n\xa0 1. 반기순이익\n93,407,546,406\n244,820,466,832\n\xa0 2. 조정\n40\n636,122,352,332\n479,672,255,231\n\xa0 3. 영업활동으로 인한 자산ㆍ부채의 변동\n40\n(2,967,694,537,004)\n(533,967,611,216)\n\xa0 4. 이자의 수취\n1,157,907,342,245\n1,262,331,367,274\n\xa0 5. 이자의 지급\n(1,888,574,469)\n(1,303,740,122)\n\xa0 6. 배당금의 수취\n160,266,641,258\n126,453,138,271\n\xa0 7. 법인세부담액\n(371,572,751,243)\n31,276,872,121\nII. 투자활동으로 인한 현금흐름\n398,822,970,043\xa0\n(1,617,257,706,440)\n\xa0 1. 매도가능금융자산의 처분\n4,407,756,801,312\n4,423,408,861,610\n\xa0 2. 만기보유금융자산의 상환\n29,757,084,267\n34,546,870,927\n\xa0 3. 위험회피목적파생상품의 정산\n(245,298,172,093)\n402,847,084,569\n\xa0 4. 관계ㆍ종속기업투자의 처분\n116,124,046,214\n184,893,824,595\n\xa0 5. 관계ㆍ종속기업투자 관련 배당\n158,639,202,114\n75,124,993,320\n\xa0 6. 투자부동산 및 유형자산의 처분\n125,019,700\n157,050,000\n\xa0 7. 무형자산의 처분\n-\n155,115,000\n\xa0 8. 예치보증금의 감소\n16,908,308,488\n34,218,534,171\n\xa0 9. 매도가능금융자산의 취득\n(3,042,557,990,435)\n(3,925,842,006,919)\n\xa0 10. 만기보유금융자산의 취득\n-\n(1,707,221,621,722)\n\xa0 11. 관계ㆍ종속기업투자의 취득\n(992,441,028,710)\n(1,049,037,751,117)\n\xa0 12. 투자부동산 및 유형자산의 취득\n(35,062,013,664)\n(53,918,416,871)\n\xa0 13. 무형자산의 취득\n(14,175,744,470)\n(5,023,208,962)\n\xa0 14. 예치보증금의 증가\n(952,542,680)\n(31,567,035,041)\nIII. 재무활동으로 인한 현금흐름\n(126,577,721,879)\n943,420,282,526\n\xa0 1. 배당금의 지급\n(75,139,025,000)\n(105,194,635,000)\n\xa0 2. 리스부채의 상환\n(13,261,846,879)\n-\n\xa0 3. 신종자본증권의 발행\n-\n1,060,069,917,526\n\xa0 4. 신종자본증권의 배당\n(38,176,850,000)\n(11,455,000,000)\nIV. 현금및현금성자산의 순증감(I + II + III)\n(1,021,206,732,311)\n935,445,324,477\nV. 기초 현금및현금성자산\n1,412,191,890,071\n301,761,539,784\nVI. 외화표시 현금및현금성자산 환율변동효과\n301,590,818\n34,007,532,781\nⅦ. 당반기말 현금및현금성자산\n391,286,748,578\n1,271,214,397,042\n']"
